RT Journal Article
SR Electronic
T1 Hand Dermatitis among Health Care Workers during the COVID-19 Pandemic: Prevalence, and Risk Factors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.06.27.22276976
DO 10.1101/2022.06.27.22276976
A1 Omolbanin Motamed-Rezaei
A1 Gholamreza Sharif-Zadeh
A1 Hadis Rajabipour
A1 Farnaz Jahani
A1 Hamed Lotfi
YR 2022
UL http://medrxiv.org/content/early/2022/06/28/2022.06.27.22276976.abstract
AB Background Health care workers (HCWs) need to perform new preventive measures to protect themselves and patients against ongoing COVID-19 transmission, which can increase the occurrence of hand dermatitis (HD) among them.Objectives This study aimed to investigate the prevalence of HD among HCWs and its possible risk factors in IRAN.Methods A survey of 159 HCWS working in university hospitals was performed between August to September 2020. Research data were collected via the standardized Nordic Occupational Skin Questionnaire (NOSQ-2002).Results The prevalence of HD in the study population was 51.6%. Females had a 3.84 fold higher risk of HD than males (confidence interval (CI): 1.85-8). HCWs older than 40 years and those who aged 30-39 years had a 9.6 and 1.72 fold higher risk of HD than HCWs aged 20-29 years (CI: 2.6-35.7; CI: 0.87-3.4, respectively). A significant association was found between the prevalence of HD among HCWs and working hours per week, and wearing gloves (P<0.05).Conclusion Possible risk factors for developing HD among HCWs are female gender and older age. Preventive measures for HD are needed for HCWs, especially during the COVID- 19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:the research ethics committee on Research Ethics at Birjand University of Medical Sciences approved code: 3789 ethics code: ir.bums.REC.1398.8I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors